Blockade of TLR9 agonist-induced type I interferons promotes inflammatory cytokine IFN-γ and IL-17 secretion by activated human PBMC
Authors:
- John A. MeyersJMJohn A. Meyers
- Alyson J. ManginiAMAlyson J. Mangini
- Taro NagaiTNTaro Nagai
- Calvin F. RoffCRCalvin F. Roff
- David SehyDSDavid Sehy
- Gijs A. van SeventerGSGijs A. van Seventer
- Jean Maguire van SeventerJSJean Maguire van Seventer
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005
- Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis CClinical Rheumatology, 2004
- Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activitiesEuropean Journal of Immunology, 2003
- Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB MiceJournal of Experimental Medicine, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodJournal of Experimental Medicine, 2003
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- Interleukin-12 and the regulation of innate resistance and adaptive immunityNature Reviews Immunology, 2003
- The natural interferon-α producing cells in systemic lupus erythematosusHuman Immunology, 2002
- Polyinosinic acid: polycytidylic acid promotes T helper type 1‐specific immune responses by stimulating macrophage production of interferon‐α and interleukin‐12European Journal of Immunology, 1995